Progress Report on Access to Hepatitis C Treatment. WHO. (2018)


This report updates the first edition, published in 2016, and reviews the progress countries have made in expanding access to life-saving DAAs. The report reviews the main challenges countries face and describes recent developments in relation to five key factors that determine access to DAA medicines: affordability, quality assurance, regulatory approval, government commitment and financing. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners. 

Keywords: HCV, treatment, medicines, response


Download Publication

  Previous Next  

Data Dashboard
Highlighted publications
Calendar of events